Webinar on

Renal Diseases and Management

May 27, 2021

Scientific Program

Keynote Session:

Oral Session 1:

  • Acute and Chronic Kidney Diseases
Meetings International -  Conference Keynote Speaker Rosario Cianci photo

Rosario Cianci

Sapienza University of Rome, Italy

Title: Activation of human renal progenitors cells after revascularization in ischemic nephropathy. Possible instrumental laboratoristic and clinical predictors

Biography:

Rosario Cianci has a specialist in Nephrology, Associate Professor of Nephrology, He work in Rome at the Umberto I Polyclinic, where I manage the Malpighi Center for Hypertension and Vascular Diseases and the Nephrology Unit at the La Sapienza University of Rome. The fields of interest are arterial hypertension, vascular diseases associated with arterial hypertension and primary and secondary renal diseases and also gained particular experience in the study of renal vascular diseases and above all renal artery stenosis

Abstract:

Ischemic nephropaty (IN)is associated with an increased risk for progressive decline in renal function especially when present from a long time. The most common cause of IN  is related to renal artery stenosis (RAS) and this is in a mayor of case do to atherosclerotic lesions, and with minor impact by fibromuscular dysplasia. Percutaneous transluminal renal angioplasty (PTRA) with or without stenting is one of the standard treatments for severe RAS. It’s also estabilshed    the correct timing of revascularization before hypoxia led to irreversible kidney damage. Randomized controlled trials comparing medical therapy with PTRA to medical therapy alone have failed to show a benefit of PTRA; however diferent studies have valuated the effects of PTRA treatment only on  blood pressure and renal function and never studied wich factors were could be able to repairs the organ demage. As demostratde that   in the adult human kidney, CD133, CD24  cells are a  progenitors that are arranged in a precise sequence within Bowman’s capsule and exhibit heterogeneous potential for differentiation and regeneration. Using the dosage of renal staminal cells  we identifies and confim factors (clinicale and strumentals) that may predict which patients are most likely to benefit from PTRA.

Meetings International -  Conference Keynote Speaker K.Sampathkumar  photo

K.Sampathkumar

Meenakshi Mission Hospital and Research Centre Madurai, India

Title: Prevention of Progression of CKD- Newer Evidences

Biography:

Prof. K.Sampathkumar MD DM FRCP [Glas] FASN  working in Department of Nephrology, Meenakshi Mission Hospital and Research Centre

Abstract:

Chronic Kidney Disease [ CKD ] afflicts approximately 7-10% of Adult Population. The manifestations of CKD are varied and can mimic a variety of medical and surgical conditions.  It is a silent killer due to its far reaching ill effects on the cardiovascular system. Early recognition is of paramount importance since preventive strategies are successful only if applied before irreversible renal fibrosis sets in. This talk will provide an  overview of Paradigm shift in our focus on various risk factors.

 The old fashioned recommendation of  blanket dietary Protein restriction now applies more  to meat based diets and not for vegetable proteins. Multiple lines of evidences are in favour of  Plant Based dietary   Protein intake  with reno protective benefits  due to their  alkaline nature and fibre content. In addition, Plant Based Protein intrake results in reduced Phosphate absorption which is advantageous in curtailing release of FGF-23 and PTH.Â